Higher systemic immune-inflammation index and systemic inflammation response index levels are associated with stroke prevalence in the asthmatic population: a cross-sectional analysis of the NHANES 1999-2018

• DOI: 10.3389/fimmu.2023.1191130
• Publication Date: 2023-08-04T12:00:29Z
• Authors: Wenke Cheng; Xiancong Bu; Chunhua Xu; Grace Wen; Fanliang Kong; Huachun Pan; Shumin Yang; Siwei Chen
• Keywords: Stroke; Quartile; Cross-sectional study; Rank correlation

Background Significant evidence suggests that asthma might originate from low-grade systemic inflammation. Previous studies have established a positive association between the immune-inflammation index (SII) and inflammation response (SIRI) levels risk of stroke. However, it remains unclear whether SII, SIRI prevalence stroke are related in individuals with asthma. Methods The present cross-sectional study used data National Health Nutrition Examination Survey (NHANES) conducted 1999 2018. SII was calculated using following formula: (platelet count × neutrophil count) / lymphocyte count. (neutrophil monocyte count)/lymphocyte Spearman rank correlation coefficient to determine any SIRI, baseline characteristics. Survey-weighted logistic regression employed calculate odds ratios (ORs) 95% confidence intervals (CIs) prevalence. predictive value for assessed through receiver operating characteristic (ROC) curve analysis, area under ROC (AUC) being indicative its value. Additionally, clinical models including coronary heart disease, hypertension, age, poverty income ratio were constructed evaluate their applicability. Results Between 2018, 5,907 NHANES participants identified, which 199 experienced stroke, while remaining 5,708 had not. analysis indicated neither nor exhibited significant characteristics (r<0.1). curves optimal cut-off values classify into low- high-level groups. Higher associated higher ORs 1.80 (95% CI, 1.18-2.76) 2.23 1.39-3.57), respectively. (AUC=0.618) superior (AUC=0.552). Furthermore, model demonstrated good (AUC=0.825), sensitivity 67.1% specificity 87.7%. Conclusion In asthmatics, significantly increased more pronounced coexisting obesity hyperlipidaemia. relatively stable novel inflammatory markers asthmatic population, having better than SII.